Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. 　
          
　
There are 20 News items on Display.
Latest News　

HighLight
1. KFDA held the largest number of consultations about the commercialization of CNS drugs

The Center for Drug Development Assistance under the KFDA announced that it held a total of 381 consultations about the commercialization of ..
 

July 1st, 2009
2. Janssen Korea and Daewoong sign a co-promotion agreement for Ultracet

Janssen Korea and Daewoong Pharm recently signed a co-promotion agreement for Ultracet (acetaminophen + tramadol hydrochloride) tab., a non- ..
 

July 1st, 2009
3. Handok to introduce a continuous blood glucose monitor

Handok Pharm recently signed a license agreement with Echo Therapeutics (the U.S.) to introduce SymphonyTM transdermal Continuous Glucose Mo ..
 

July 1st, 2009
more ...
Business News
4. KIT and KIRAMS to jointly develop new drugs related to radiotherapy

The Korea Institute of Toxicology (KIT) recently signed an MOU for collaborative research in the field of radiology with the Korea Institute ..
 

July 1st, 2009
5. Three new drugs launched

Three new drugs were recently launched under mandatory 6-year post marketing surveillance (PMS) period. Jeil Pharm launched Protos (strontiu ..
 

July 1st, 2009
6. Samjin to focus on circulatory diseases and dementia markets.

Samjin Pharm announced that it will actively foster its three products, such as Platless (clopidogrel) tab. for the treatment of thrombosis, ..
 

July 1st, 2009
7. MSD Korea and Samchundang sign a co-promotion agreement for six ophthalmics

 MSD Korea and Samchundang Pharm recently signed a co-promotion agreement for six ophthalmic drugs for the treatment of glaucoma, inclu ..
 

July 1st, 2009
8. Janssen Korea and Daewoong sign a co-promotion agreement for Ultracet

Janssen Korea and Daewoong Pharm recently signed a co-promotion agreement for Ultracet (acetaminophen + tramadol hydrochloride) tab., a non- ..
 

July 1st, 2009
more ...
Policy and Regulatory
9. KFDA held the largest number of consultations about the commercialization of CNS drugs

The Center for Drug Development Assistance under the KFDA announced that it held a total of 381 consultations about the commercialization of ..
 

July 1st, 2009
10. Price of Glivec to be reduced by 14%

Novartis Korea agreed to reduce the reimbursement price of Glivec (imatinib mesylate) film coated tab. by 14 percent after six negotiations ..
 

June 23rd, 2009
more ...
Bio industry news
11. ATGen signs supply agreements with companies in the U.S. and Europe

ATGen, a local bio-venture company, recently signed an agreement with Cell Sciences (the U.S.) to supply about 400 different protein and ant ..
 

July 1st, 2009
12. Huons developing a bee venom-based drug for the treatment of Parkinson′s disease

Huons, a KOSDAQ-listed pharmaceutical firm, recently announced that it successfully completed an efficacy study for bee venom for the treatm ..
 

July 1st, 2009
more ...
R & D
13. Phase I clinical trial for OCT-1547 for the treatment of osteoporosis initiated

Oscotec, a local company engaged in bone metabolism research, recently announced that Kendle International Inc., which is Oscotec? partner a ..
 

July 1st, 2009
14. MIHWAF and Sanofi-Aventis sign an MOU for R&D

Sanofi-Aventis recently signed an MOU with the Ministry for Health, Welfare and Family Affairs (MIHWAF) to invest a total of ￦70 billion in ..
 

July 1st, 2009
more ...
Patent
15. Korea United Pharm obtains two patents for bitter taste-masked formulations

Korea United Pharm obtained a Korean patent for ′Oral composition of clarithromycin in bitter taste-masked formulation and a method fo ..
 

July 1st, 2009
16. Number of patent applications for orally disintegrating tablets continuously increasing

According to the Korean Intellectual Property Office (KIPO), a total of 109 patent applications for orally disintegrating tablets (ODTs) hav ..
 

June 23rd, 2009
17. Oscotec obtains a patent for a compound for the treatment of arthritis

Oscotec, a local company engaged in bone metabolism research, recently obtained a Korean patent for a compound which inhibits the secretion ..
 

June 16th, 2009
more ...
Company profile
18. Summary of Korea pharmaceutical manufacturer

Summary of Korea pharmaceutical manufacturer (Dongkook & LG Life Sciences)Please download the attached file.
 

July 1st, 2009
19. Summary of Korea pharmaceutical manufacturer

Summary of Korea Pharmaceutical Manufacturers (Kunwha Pharm & Samsung Pharm) Please download the attached file.
 

June 1st, 2009
20. Summary of Korea pharmaceutical manufacturer

Summary of Korea Pharmaceutical manufacturer (SamA & Shinpoong)Please download the attached file.
 

May 4th, 2009
more ...
　
Pharma Koreana Ltd. 14th floor, KTB Network Bldg., 826-14, Yeoksam, Kangnam-gu, Seoul135-080 ,KOREA Tel:(82)2-554-9591 Fax:(82)2-563-8289 　 　

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com